Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study

F Wang, YK Zhao, M Li, Z Zhu… - Cutaneous and Ocular …, 2017 - Taylor & Francis
Purpose: Morbidity due to cutaneous adverse drug reactions (CADRs) is quite common. The
specific culprit drugs change over time and clinicians must be kept informed with updated …

[HTML][HTML] Adverse drug reactions in primary care: a scoping review

H Khalil, C Huang - BMC health services research, 2020 - Springer
Background Medication-related adverse events, or adverse drug reactions (ADRs) are
harmful events caused by medication. ADRs could have profound effects on the patients' …

Drug induced uveitis

JC Parra, M Díaz-Llopis - Archivos de la Sociedad …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose To review the world literature about drug induced uveitis. Methods We used the
OMS and Naranjo criteria of causality of adverse drug reactions to classify the causes of …

Ocular adverse effects of therapeutic biologics

HV Neves da Silva, J Placide… - Therapeutic …, 2022 - journals.sagepub.com
Biological drugs, termed biologics, are medications that contain or are derived from a living
organism (human, animal, or microorganism). With new biological agents being approved …

[HTML][HTML] Neuro-ophthalmic complications of modern anti-cancer drugs

JA Oskam, HV Danesh-Meyer - Graefe's Archive for Clinical and …, 2024 - Springer
Purpose Targeted cancer therapies have been responsible for a dramatic shift in treatment
strategies for cancer, and the number of drugs, classes, and indications are continually …

[引用][C] Ocular adverse effects of anti-cancer chemotherapy

P Singh, A Singh - J Cancer Ther Res, 2012

Ocular disorders of anticancer drugs--ocular side effects

H Kashiwagi - Gan to Kagaku ryoho. Cancer & Chemotherapy, 2010 - europepmc.org
Although there are some sporadic reports about the ocular side effects (see below-named
ocular disorders) of anticancer drugs, extremely few well-organized reports have been …

Active pharmacovigilance in peruvian population: Surveillance of a timolol/brimonidine/dorzolamide ophthalmic fixed combination

H Contreras-Salinas, M Barajas-Hernández… - Clinical …, 2021 - Taylor & Francis
Purpose In this study active pharmacovigilance was used in an uncontrolled population to
enrich the safety profile and canvass the Adverse Drug Reactions (ADRs) associated with …

Differences in Ocular Adverse Events Associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

G Chen, L Zhang, ST Zhao, H Huang… - Expert Opinion on Drug …, 2024 - Taylor & Francis
Objective Our study aims to characterize the ocular safety profiles of phosphodiesterase type
5 (PDE5) inhibitors and explore the differences among different PDE5 inhibitors. Methods …

[引用][C] Principles of therapy

F Ziemssen, M Zierhut - Drug-Induced Ocular Side Effects, 2015 - Elsevier